Furthermore, elevated SIRPG transcript levels in PBMCs and/or protein levels in serum have been observed in patients with T1D, diabetic retinopathy, and active lupus (but not inactive lupus) (11–16), suggesting SIRPG promotes immune responses and contributes to autoimmune pathogenesis. Here, SIRPG is linked to type 1 diabetes mellitus.